![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Terminated |
Unique ID issued by UMIN | UMIN000004319 |
Receipt No. | R000005176 |
Scientific Title | Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate |
Date of disclosure of the study information | 2010/10/04 |
Last modified on | 2012/12/21 |
Basic information | ||
Public title | Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate | |
Acronym | Clinical pharmacological study of [11C]S-dThd | |
Scientific Title | Clinical pharmacological study of [11C]S-dThd reflecting DNA synthesis rate | |
Scientific Title:Acronym | Clinical pharmacological study of [11C]S-dThd | |
Region |
|
Condition | ||
Condition | Cancer | |
Classification by specialty |
|
|
Classification by malignancy | Malignancy | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | To confirm safety of [11C] S-dThd, to analyze the pharmacokinetics, to estimate the exposure dose, and to evaluate the tumor accumulation. |
Basic objectives2 | Safety |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Safety, pharmacokinetics, exposure dose, and tumor accumulation |
Key secondary outcomes |
Base | |
Study type | Interventional |
Study design | |
Basic design | Single arm |
Randomization | Non-randomized |
Randomization unit | |
Blinding | Open -no one is blinded |
Control | Uncontrolled |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 1 | |
Purpose of intervention | Prevention | |
Type of intervention |
|
|
Interventions/Control_1 | [11C] S-dThd PET/CT | |
Interventions/Control_2 | ||
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | Untreated cancer patients | |||
Key exclusion criteria | - Severe heart disease (≥ NYHA class II)
- Severe renal dysfunction - Performance Status (PS)≥2; intolerable to PET scanning - Lack in ability to give an informed consent - Patients regarded as unsuitable by responsible investigators |
|||
Target sample size | 6 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | National Institute of Radiological Sciences | ||||||
Division name | Molecular Imaging Center | ||||||
Zip code | |||||||
Address | 4-9-1 Anagawa Inage, Chiba | ||||||
TEL | |||||||
Public contact | |||||||
Name of contact person |
|
||||||
Organization | National Institute of Radiological Sciences | ||||||
Division name | Molecular Imaging Center | ||||||
Zip code | |||||||
Address | 4-9-1 Anagawa Inage, Chiba | ||||||
TEL | |||||||
Homepage URL | |||||||
Sponsor | |
Institute | National Institute of Radiological Sciences |
Institute | |
Department |
Funding Source | |
Organization | National Institute of Radiological Sciences |
Organization | |
Division | |
Category of Funding Organization | Other |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Terminated | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry |
|
||||||
Date trial data considered complete |
|
||||||
Date analysis concluded |
|
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005176 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |